Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Rory M Shallis
Yale University Cancer Center LAO
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
- Mayo Clinic Hospital in Arizona
Phoenix, Arizona, United States
- Uc Irvine Health Cancer Center-Newport
Costa Mesa, California, United States
- Uci Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California, United States
- Uci Health Laguna Hills
Laguna Hills, California, United States
- Los Angeles General Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Yale University
New Haven, Connecticut, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Uc Comprehensive Cancer Center at Silver Cross
New Lenox, Illinois, United States
- University of Chicago Medicine-Orland Park
Orland Park, Illinois, United States
- University of Kansas Cancer Center
Kansas City, Kansas, United States
- University of Kansas Hospital-Westwood Cancer Center
Westwood, Kansas, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- University of Maryland/greenebaum Cancer Center
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Nyp/weill Cornell Medical Center
New York, New York, United States
- Montefiore Medical Center - Moses Campus
The Bronx, New York, United States
- Montefiore Medical Center-Einstein Campus
The Bronx, New York, United States
- Montefiore Medical Center-Weiler Hospital
The Bronx, New York, United States
- Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- University of Cincinnati Cancer Center-Uc Medical Center
Cincinnati, Ohio, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- University of Cincinnati Cancer Center-West Chester
West Chester, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- University of Pittsburgh Cancer Institute (upci)
Pittsburgh, Pennsylvania, United States
- Huntsman Cancer Institute/university of Utah
Salt Lake City, Utah, United States
- University of Virginia Cancer Center
Charlottesville, Virginia, United States
- Vcu Massey Comprehensive Cancer Center
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Jun 2023
- Primary completion
- 31 Aug 2026
- Completion
- 31 Aug 2026
- Last update posted
- 13 May 2026
- Registered enrollment
- 132
- Registry id
- NCT05600894
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.